Robert I Haddad (Robert Haddad)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Squamous Cell Carcinoma

Radiation Induced

Lymph Node Metastasis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Min Kyung Lee, Ze Zhang, Kartik Sehgal, Rondi A Butler, Hannah Stolrow, Geat Ramush, Keisuke Shirai, Devin C Koestler, Lucas A Salas, John K Wiencke, Robert I Haddad, Karl T Kelsey, Brock C Christensen
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. Epigenomics (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Min Kyung Lee, Ze Zhang, Kartik Sehgal, Rondi A Butler, Hannah Stolrow, Geat Ramush, Keisuke Shirai, Devin C Koestler, Lucas A Salas, John K Wiencke, Robert I Haddad, Karl T Kelsey, Brock C Christensen
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. Epigenomics 16 (11-12) (2024)
Min Kyung Lee, Ze Zhang, Kartik Sehgal, Rondi A Butler, Hannah Stolrow, Geat Ramush, Keisuke Shirai, Devin C Koestler, Lucas A Salas, John K Wiencke, Robert I Haddad, Karl T Kelsey, Brock C Christensen
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. Epigenomics (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi, Kartik Sehgal, Donald J Annino, Laura A Goguen, Robert I Haddad, Roy B Tishler, Danielle N Margalit, Ravindra Uppaluri, Jonathan D Schoenfeld, Eleni M Rettig
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi, Kartik Sehgal, Donald J Annino, Laura A Goguen, Robert I Haddad, Roy B Tishler, Danielle N Margalit, Ravindra Uppaluri, Jonathan D Schoenfeld, Eleni M Rettig
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi, Kartik Sehgal, Donald J Annino, Laura A Goguen, Robert I Haddad, Roy B Tishler, Danielle N Margalit, Ravindra Uppaluri, Jonathan D Schoenfeld, Eleni M Rettig
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Min Kyung Lee, Ze Zhang, Kartik Sehgal, Rondi A Butler, Hannah Stolrow, Geat Ramush, Keisuke Shirai, Devin C Koestler, Lucas A Salas, John K Wiencke, Robert I Haddad, Karl T Kelsey, Brock C Christensen
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. Epigenomics 16 (11-12) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi, Kartik Sehgal, Donald J Annino, Laura A Goguen, Robert I Haddad, Roy B Tishler, Danielle N Margalit, Ravindra Uppaluri, Jonathan D Schoenfeld, Eleni M Rettig
Personalized circulating tumor DNA for monitoring disease status in head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Glenn J Hanna, Michael J Dennis, Nicole Scarfo, Michelle S Mullin, Rosh K V Sethi, Kartik Sehgal, Donald J Annino, Laura A Goguen, Robert I Haddad, Roy B Tishler, Danielle N Margalit, Ravindra Uppaluri, Jonathan D Schoenfeld, Eleni M Rettig
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de Los Reyes, Craig Barker, Jessica Whiteley, Robert I Haddad, Lisa F Licitra, Matthew J Ferris, Jérôme Fayette, Dan P Zandberg, Lillian L Siu, Ricard Mesía
Tumor Mutational Burden as a Predictor of Survival With Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Andrew Albright, Robin Mogg, Mark Ayers, Lingkang Huang, Jared Lunceford, Razvan Cristescu, Jonathan Cheng, Ranee Mehra
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Robert I Haddad, Kevin J Harrington, Makato Tahara, Matthew J Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabil F Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo C Girotto, Miguel Angel Alvarez Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander D Guminski, Urs D A Müller-Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Li Wei, Athanassios Argiris
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Liye Zhou, Zexian Zeng, Ann Marie Egloff, Fan Zhang, Fei Guo, Katie M Campbell, Peter Du, Jingxin Fu, Paul Zolkind, Xiaojing Ma, Zhe Zhang, Yi Zhang, Xiaoqing Wang, Shengqing Gu, Rachel Riley, Yasutaka Nakahori, Joshua Keegan, Robert I Haddad, Jonathan D Schoenfeld, Obi Griffith, Robert T Manguso, James A Lederer, X Shirley Liu, Ravindra Uppaluri
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders. Journal for immunotherapy of cancer 10 (1) (2022)
Alan L Ho, Irene Brana, Robert I Haddad, Jessica Bauman, Keith C Bible, Sjoukje Oosting, Deborah J Wong, Myung-Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin J Harrington, Sung-Bae Kim, Lisa F Licitra, Ioanna Nixon, Nabil F Saba, Stephan Hackenberg, Pol Specenier, Francis Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Yu-Pei Chen, Nofisat Ismaila, Matthew Chin Heng Chua, A Dimitrios Colevas, Robert I Haddad, Shao Hui Huang, Joseph T S Wee, Alexander C Whitley, Jun-Lin Yi, Sue S Yom, Anthony T C Chan, Chao-Su Hu, Jin-Yi Lang, Quynh-Thu Le, Anne W M Lee, Nancy Y Lee, Jin-Ching Lin, Brigette Buig Yue Ma, Thomas J Morgan, Jatin Shah, Ying Sun, Yuyao Sun
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)